
Interleukin‐ (IL‐) 38 is a recently discovered cytokine and is the tenth member of the IL‐1 cytokine family. IL‐38 shares structural features with IL‐1 receptor antagonist (IL‐1Ra) and IL‐36Ra. IL‐36R is the specific receptor of IL‐38, a partial receptor antagonist of IL‐36. IL‐38 inhibits the production of T‐cell cytokines IL‐17 and IL‐22. IL‐38 also inhibits the production of IL‐8 induced by IL‐36γ, thus inhibiting inflammatory responses. IL‐38‐related cytokines, including IL‐1Ra and IL‐36Ra, are involved in the regulation of inflammation and immune responses. The study of IL‐38 and IL‐38‐related cytokines might provide new insights for developing anti‐inflammatory treatments in the near future.
Inflammation, Interleukins, Review Article, Receptors, Interleukin, Interleukin 1 Receptor Antagonist Protein, Pathology, RB1-214, Animals, Cytokines, Humans, Signal Transduction
Inflammation, Interleukins, Review Article, Receptors, Interleukin, Interleukin 1 Receptor Antagonist Protein, Pathology, RB1-214, Animals, Cytokines, Humans, Signal Transduction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 66 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
